Free Access
Med Sci (Paris)
Volume 27, Number 6-7, Juin–Juillet 2011
Page(s) 619 - 625
Section M/S Revues
Published online 01 July 2011
  1. Wu JT, Kral JG. The NF-kappaB/IkappaB signaling system: a molecular target in breast cancer therapy. J Surg Res 2005 ; 123 : 158-169. [CrossRef] [PubMed] [Google Scholar]
  2. Hayden MS, Ghosh S. Shared principles in NF-kappaB signaling. Cell 2008 ; 132 : 344-362. [CrossRef] [PubMed] [Google Scholar]
  3. Clement JF, Meloche S, Servant MJ. The IKK-related kinases: from innate immunity to oncogenesis. Cell Res 2008 ; 18 : 889-899. [CrossRef] [PubMed] [Google Scholar]
  4. Shimada T, Kawai T, Takeda K, et al. IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IkappaB kinases. Int Immunol 1999 ; 11 : 1357-1362. [CrossRef] [PubMed] [Google Scholar]
  5. Peters RT, Liao SM, Maniatis T. IKKepsilon is part of a novel PMA-inducible IkappaB kinase complex. Mol Cell 2000 ; 5 : 513-522. [CrossRef] [PubMed] [Google Scholar]
  6. Kishore N, Huynh QK, Mathialagan S, et al. IKK-i and TBK-1 are enzymatically distinct from the homologous enzyme IKK-2: comparative analysis of recombinant human IKK-i, TBK-1, and IKK-2. J Biol Chem 2002 ; 277 : 13840-13847. [CrossRef] [PubMed] [Google Scholar]
  7. Kravchenko VV, Mathison JC, Schwamborn K, et al. IKKi/IKKepsilon plays a key role in integrating signals induced by pro-inflammatory stimuli. J Biol Chem 2003 ; 278 : 26612-26619. [CrossRef] [PubMed] [Google Scholar]
  8. Tenoever BR, Ng SL, Chua MA, et al. Multiple functions of the IKK-related kinase IKKepsilon in interferon-mediated antiviral immunity. Science 2007 ; 315 : 1274-1278. [CrossRef] [PubMed] [Google Scholar]
  9. Sweeney SE, Hammaker D, Boyle DL, Firestein GS. Regulation of c-Jun phosphorylation by the IkappaB kinase-epsilon complex in fibroblast-like synoviocytes. J Immunol 2005 ; 174 : 6424-6430. [PubMed] [Google Scholar]
  10. Wang N, Ahmed S, Haqqi TM. Genomic structure and functional characterization of the promoter region of human IkappaB kinase-related kinase IKKi/IKKvarepsilon gene. Gene 2005 ; 353 : 118-133. [CrossRef] [PubMed] [Google Scholar]
  11. Hutti JE, Shen RR, Abbott DW, et al. Phosphorylation of the tumor suppressor CYLD by the breast cancer oncogene IKKepsilon promotes cell transformation. Mol Cell 2009 ; 34 : 461-472. [CrossRef] [PubMed] [Google Scholar]
  12. Guo JP, Shu SK, Esposito NN, et al. IKKepsilon phosphorylation of estrogen receptor alpha Ser-167 and contribution to tamoxifen resistance in breast cancer. J Biol Chem 2010 ; 285 : 3676-3684. [CrossRef] [PubMed] [Google Scholar]
  13. Vallabhapurapu S, Karin M. Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol 2009 ; 693-733. [CrossRef] [PubMed] [Google Scholar]
  14. Perry AK, Chow EK, Goodnough JB, et al. Differential requirement for TANK-binding kinase-1 in type I interferon responses to toll-like receptor activation and viral infection. J Exp Med 2004 ; 199 : 1651-1658. [CrossRef] [PubMed] [Google Scholar]
  15. Hemmi H, Takeuchi O, Sato S, et al. The roles of two IkappaB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection. J Exp Med 2004 ; 199 : 1641-1650. [CrossRef] [PubMed] [Google Scholar]
  16. Boehm JS, Zhao JJ, Yao J, et al. Integrative genomic approaches identify IKBKε as a breast cancer oncogene. Cell 2007 ; 129 : 1065-1079. [CrossRef] [PubMed] [Google Scholar]
  17. Eddy SF, Guo S, Demicco EG, et al. Inducible IkappaB kinase/IkappaB kinase epsilon expression is induced by CK2 and promotes aberrant nuclear factor-kappaB activation in breast cancer cells. Cancer Res 2005 ; 65 : 11375-11383. [CrossRef] [PubMed] [Google Scholar]
  18. Nomura F, Kawai T, Nakanishi K, Akira S. NF-kappaB activation through IKK-i-dependent I-TRAF/TANK phosphorylation. Genes Cells 2000 ; 5 : 191-202. [CrossRef] [PubMed] [Google Scholar]
  19. Adli M, Baldwin AS. IKK-i/IKKepsilon controls constitutive, cancer cell-associated NF-kappaB activity via regulation of Ser-536 p65/RelA phosphorylation. J Biol Chem 2006 ; 281 : 26976-26984. [CrossRef] [PubMed] [Google Scholar]
  20. Mattioli I, Geng H, Sebald A, et al. Inducible phosphorylation of NF-kappaB p65 at serine 468 by T cell costimulation is mediated by IKK epsilon. J Biol Chem 2006 ; 281 : 6175-6183. [CrossRef] [PubMed] [Google Scholar]
  21. Harris J, Oliere S, Sharma S, et al. Nuclear accumulation of cRel following C-terminal phosphorylation by TBK1/IKKepsilon. J Immunol 2006 ; 177 : 2527-2535. [PubMed] [Google Scholar]
  22. Sharma S, tenOever BR, Grandvaux N, et al. Triggering the interferon antiviral response through an IKK-related pathway. Science 2003 ; 300 : 1148-1151. [CrossRef] [PubMed] [Google Scholar]
  23. Fitzgerald KA, McWhirter SM, Faia KL, et al. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 2003 ; 4 : 491-496. [CrossRef] [PubMed] [Google Scholar]
  24. Huang W, Ghisletti S, Perissi V, et al. Transcriptional integration of TLR2 and TLR4 signaling at the NCoR derepression checkpoint. Mol Cell 2009 ; 35 : 48-57. [CrossRef] [PubMed] [Google Scholar]
  25. Seo SI, Song SY, Kang MR, et al. . Immunohistochemical analysis of NF-kappaB signaling proteins IKKepsilon, p50/p105, p52/p100 and RelA in prostate cancers. Apmis 2009 ; 117 : 623-628. [CrossRef] [PubMed] [Google Scholar]
  26. Guo JP, Shu SK, He L, et al. Deregulation of IKBKε is associated with tumor progression, poor prognosis, and cisplatin resistance in ovarian cancer. Am J Pathol 2009 ; 175 : 324-333. [CrossRef] [PubMed] [Google Scholar]
  27. Sovak MA, Bellas RE, Kim DW, et al. Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer. J Clin Invest 1997 ; 100 : 2952-2960. [CrossRef] [PubMed] [Google Scholar]
  28. Romieu-Mourez R, Kim DW, Shin SM, et al. Mouse mammary tumor virus c-rel transgenic mice develop mammary tumors. Mol Cell Biol 2003 ; 23 : 5738-5754. [CrossRef] [PubMed] [Google Scholar]
  29. Sun SC. CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes. Cell Death Differ 2010 ; 17 : 25-34. [CrossRef] [PubMed] [Google Scholar]
  30. Zhang M, Wu X, Lee AJ, et al. Regulation of IkappaB kinase-related kinases and antiviral responses by tumor suppressor CYLD. J Biol Chem 2008 ; 283 : 18621-18626. [CrossRef] [PubMed] [Google Scholar]
  31. Barone I, Brusco L, Fuqua SA. Estrogen receptor mutations and changes in downstream gene expression and signaling. Clin Cancer Res 2010 ; 16 : 2702-2708. [CrossRef] [PubMed] [Google Scholar]
  32. Lee DF, Hung MC. Advances in targeting IKK and IKK-related kinases for cancer therapy. Clin Cancer Res 2008 ; 14 : 5656-5662. [CrossRef] [PubMed] [Google Scholar]
  33. Clark K, Plater L, Peggie M, Cohen P. Use of the pharmacological inhibitor BX795 to study the regulation and physiological roles of TBK1 and IkappaB kinase epsilon: a distinct upstream kinase mediates Ser-172 phosphorylation and activation. J Biol Chem 2009 ; 284 : 14136-14146. [CrossRef] [PubMed] [Google Scholar]
  34. Baud V, Jacque E. The alternative NF-κB activation pathway and cancer: friend or foe?. Med Sci (Paris) 2008 ; 24 : 1083-1088. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  35. Gautheron J, Courtois G. New functions of NEMO, the regulatory subunit of IKK. Med Sci (Paris) 2008 ; 24 : 954-959. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  36. Bonnet M, Courtois G. La déubiquitinase CYLD : une cible recurrente dans les processus oncogéniques. Med Sci (Paris) 2011 ; 27 : 626-631. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.